The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι

Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):e2024202118. doi: 10.1073/pnas.2024202118.

Abstract

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic and has claimed over 2 million lives worldwide. Although the genetic sequences of SARS-CoV and SARS-CoV-2 have high homology, the clinical and pathological characteristics of COVID-19 differ significantly from those of SARS. How and whether SARS-CoV-2 evades (cellular) immune surveillance requires further elucidation. In this study, we show that SARS-CoV-2 infection leads to major histocompability complex class Ι (MHC-Ι) down-regulation both in vitro and in vivo. The viral protein encoded by open reading frame 8 (ORF8) of SARS-CoV-2, which shares the least homology with SARS-CoV among all viral proteins, directly interacts with MHC-Ι molecules and mediates their down-regulation. In ORF8-expressing cells, MHC-Ι molecules are selectively targeted for lysosomal degradation via autophagy. Thus, SARS-CoV-2-infected cells are much less sensitive to lysis by cytotoxic T lymphocytes. Because ORF8 protein impairs the antigen presentation system, inhibition of ORF8 could be a strategy to improve immune surveillance.

Keywords: MHC-Ι; ORF8; SARS-CoV-2; immune evasion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen Presentation*
  • Autophagy / genetics
  • Autophagy / immunology
  • COVID-19 / genetics
  • COVID-19 / immunology*
  • Chlorocebus aethiops
  • Down-Regulation / immunology*
  • HEK293 Cells
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class I / immunology*
  • Humans
  • Immune Evasion*
  • Lysosomes / genetics
  • Lysosomes / immunology
  • Lysosomes / virology
  • Mice
  • Mice, Transgenic
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • Vero Cells
  • Viral Proteins / genetics
  • Viral Proteins / immunology*

Substances

  • Histocompatibility Antigens Class I
  • ORF8 protein, SARS-CoV-2
  • Viral Proteins